BioNTech SE
BioNTech SE is a Mainz-based company.
All edits
Edits on 29 Jul, 2023
Edits on 26 Aug, 2022
Bhupendra Solanki
Edits on 11 Jun, 2022
Golden AI
Edits on 15 Apr, 2022
Golden AI
Edits made to:
Infobox (+3/-2 properties)
Infobox
Latest funding round date
September 2020
Total funding amount (USD)
250,000,000
Latest funding round date
April 14, 2022
Latest funding round amount (USD)
149,999,985
Total funding amount (USD)
399,999,985
Golden AI
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Full address
AN DER GOLDGRUBE 12 MAINZ, 2M D-55131
Edits on 8 Apr, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patents assigned (count)
1
Edits on 26 Jan, 2021
Henry Ogolla
Edits made to:
Timeline (+1 events) (+332 characters)
Timeline
January 25, 2021
BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region of the PRC ("Hong Kong"), the COVID-19 vaccine COMIRNATY® based on BioNTech's proprietary mRNA technology has received authorization for emergency use in Hong Kong.
Edits on 6 Oct, 2020
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
September 2020
Edits on 17 Sep, 2020
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
250,000,000
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Is a
Location
Legal name
BioNTech SE
Legal classification
CIK number
1,776,985
Place of incorporation
Golden AI
Edits made to:
BioNTech SE
Find more companies like BioNTech SE
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
